NewKerala.com

Scientist Beena Pillai Appointed Director of Premier Biotech Institute

Dr. Beena Pillai has been appointed as the new Director of the Rajiv Gandhi Centre for Biotechnology for a five-year term. She succeeds Prof Chandrabhas Narayana and brings her internationally recognized expertise in RNA biology and neuronal development to the role. The institute is poised for expansion into high-impact areas including a bio-manufacturing hub and oncology referral hospital. Her leadership is expected to strengthen India's research-to-innovation pipeline in biotechnology.

Key Points: Dr. Beena Pillai Named Director of Rajiv Gandhi Centre for Biotechnology

  • Leadership transition at premier institute
  • Appointment for five-year term
  • Focus on RNA biology and disease research
  • Aims to accelerate national biotech initiatives
  • Successor to Prof Chandrabhas Narayana
2 min read

Scientist Beena Pillai named director of nation's premier biotech institute

Dr. Beena Pillai appointed as new Director of Rajiv Gandhi Centre for Biotechnology, bringing expertise in RNA biology to lead national research initiatives.

"Her scientific contributions have been recognised with several awards, including the National Bioscience Award - Official Release"

Thiruvananthapuram, April 16

In a key leadership transition at one of India's premier biotechnology institutions, the Rajiv Gandhi Centre for Biotechnology has appointed noted scientist Dr Beena Pillai as its new Director.

The appointment, approved by the Appointments Committee of the Union Cabinet, is for a five-year term.

Functioning under the Biotechnology Research and Innovation Council of the Department of Biotechnology, BRIC-RGCB plays a crucial national role in advancing research in disease biology, translational sciences, and technology development.

The institute has been at the forefront of efforts to bridge fundamental research with clinical and industrial applications, making the leadership change significant for India's broader biotechnology ambitions.

Dr Pillai succeeds Prof Chandrabhas Narayana, who completed his tenure in September last year, and takes charge at a time when the institute is poised for expansion into high-impact areas.

Currently a Chief Scientist at the CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB), Dr Pillai is internationally recognised for her work in RNA biology and neuronal development.

Her research has focused on the role of RNA in early development, neurogenesis, behaviour, and disease susceptibility, including the identification of microRNA markers in human diseases.

A native of Kalady, she completed her B.Sc from Ramnarain Ruia College, Mumbai, and pursued an integrated MS-PhD at the Indian Institute of Science.

She later joined CSIR-IGIB, where she established a strong research programme in genomics and molecular biology.

Her scientific contributions have been recognised with several awards, including the National Bioscience Award, the INSA Young Scientist Award, and the CSIR Young Scientist Award in Biological Sciences.

Under her leadership, BRIC-RGCB is expected to accelerate key national initiatives, including the development of a cGMP-compliant facility, a bio-manufacturing hub, and an oncology referral hospital.

The appointment is widely seen as a step towards strengthening India's research-to-innovation pipeline, with the RGCB scientific community expressing confidence in a renewed push for cutting-edge science.

- IANS

Share this article:

Reader Comments

A
Arjun K
Excellent appointment. Dr. Pillai's credentials are impeccable - from Ruia College to IISc to CSIR-IGIB. Her focus on translational science is exactly what we need to bridge the gap between lab research and actual healthcare solutions. The planned bio-manufacturing hub is a game-changer for Atmanirbhar Bharat.
R
Rohit P
While I congratulate Dr. Pillai, I hope this leadership change brings more transparency and faster project execution. Sometimes our national labs get bogged down in bureaucracy. The focus should be on delivering the cGMP facility and oncology hospital without the usual delays.
S
Sarah B
As someone working in biotech abroad, it's heartening to see India appointing leaders based on pure scientific merit. Dr. Pillai's work on microRNA markers is world-class. This sends a strong signal about India's commitment to high-quality research.
K
Karthik V
Great to see a scientist from Kerala taking charge! Her journey from a B.Sc in Mumbai to this position shows the strength of India's decentralized education system. Hope she can foster more collaboration between RGCB and other institutes in South India.
M
Michael C
The emphasis on a "research-to-innovation pipeline" is key. India has phenomenal scientific talent, but converting discoveries into products and therapies has been a challenge. Dr. Pillai's experience in a CSIR lab should help navigate this.

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50